ArticleFrontiers in cardiovascular medicine2026
Longitudinal assessment of myocardial involvement in PASC-CVS: a single-center study from China based on multiparametric CMR.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Persistent cardiac symptoms after COVID-19, termed post-acute sequelae of SARS-CoV-2 infection with cardiovascular involvement (PASC-CVS), remain poorly understood. This study aims to reveal myocardial involvement and long-term cardiac magnetic resonance (CMR) changes in PASC-CVS patients, providing insights into disease progression and recovery. Methods: This prospective single-center study in China enrolled 110 patients with PASC-CVS from March 2023 to April 2024. All participants underwent multiparametric CMR imaging to explore abnormal CMR manifestations in PASC-CVS patients. Clinical symptoms and CMR examinations were collected again one year later. Statistical analysis included the Wilcoxon signed-rank test and logistic regression. Results: Compared to controls, PASC-CVS patients exhibited significant differences in multiparametric CMR parameters, including Quantification of late gadolinium enhancement (LGE) (%) [odds ratio (OR): 6.36], Global extracellular volume (ECV) (ms) (OR: 1.33), Heart rate (bpm) (OR: 1.08), left ventricular global longitudinal strain (LV GLS) (%) (OR: 1.44), and Global native T1 (ms) (OR: 1.01). The combined multiparametric CMR parameters (Quantification of LGE, Global ECV, Heart rate, LV GLS, Global Post T1, and Global native T1) achieved an area under the curve (AUC) of 0.94, indicating excellent predictive value. At the one-year follow-up ( Conclusions: Our study reveals myocardial involvement in PASC-CVS patients, with follow-up improvements in RV EF and global T2, underscoring the utility of multiparametric CMR in monitoring and managing PASC-CVS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.